JP2010510223A5 - - Google Patents

Info

Publication number

JP2010510223A5

JP2010510223A5 JP2009537223A JP2009537223A JP2010510223A5 JP 2010510223 A5 JP2010510223 A5 JP 2010510223A5 JP 2009537223 A JP2009537223 A JP 2009537223A JP 2009537223 A JP2009537223 A JP 2009537223A JP 2010510223 A5 JP2010510223 A5 JP 2010510223A5

Authority

JP

Japan

Prior art keywords

agent

tim

antigen

activity

polypeptide

Prior art date

2007-11-15

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 claims description 61
• 239000003795 chemical substances by application Substances 0.000 claims description 39
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims description 37
• 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims description 37
• 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims description 37
• 229920001184 polypeptide Polymers 0.000 claims description 27
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 27
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 27
• 102100031351 Galectin-9 Human genes 0.000 claims description 17
• 101710121810 Galectin-9 Proteins 0.000 claims description 17
• 239000000427 antigen Substances 0.000 claims description 17
• 102000036639 antigens Human genes 0.000 claims description 17
• 108091007433 antigens Proteins 0.000 claims description 17
• 230000000694 effects Effects 0.000 claims description 17
• 239000003446 ligand Substances 0.000 claims description 14
• 210000000612 antigen-presenting cell Anatomy 0.000 claims description 12
• 206010028980 Neoplasm Diseases 0.000 claims description 9
• 241001465754 Metazoa Species 0.000 claims description 8
• 102000002689 Toll-like receptor Human genes 0.000 claims description 7
• 108020000411 Toll-like receptor Proteins 0.000 claims description 7
• 230000028993 immune response Effects 0.000 claims description 7
• 210000003169 central nervous system Anatomy 0.000 claims description 3
• 201000007455 central nervous system cancer Diseases 0.000 claims description 3
• 208000025997 central nervous system neoplasm Diseases 0.000 claims description 3
• 229940123384 Toll-like receptor (TLR) agonist Drugs 0.000 claims description 2
• 239000000556 agonist Substances 0.000 claims description 2
• 230000002708 enhancing effect Effects 0.000 claims description 2
• 239000000203 mixture Substances 0.000 description 15
• 229960005486 vaccine Drugs 0.000 description 15
• 125000003275 alpha amino acid group Chemical group 0.000 description 8
• 239000012634 fragment Substances 0.000 description 7
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 5
• 102100022338 Integrin alpha-M Human genes 0.000 description 5
• 150000001720 carbohydrates Chemical class 0.000 description 5
• 150000001413 amino acids Chemical class 0.000 description 4
• 210000004443 dendritic cell Anatomy 0.000 description 4
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• 239000003814 drug Substances 0.000 description 3
• 210000000274 microglia Anatomy 0.000 description 3
• 201000006417 multiple sclerosis Diseases 0.000 description 3
• 206010018338 Glioma Diseases 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 238000004519 manufacturing process Methods 0.000 description 2
• 210000001616 monocyte Anatomy 0.000 description 2
• 235000010987 pectin Nutrition 0.000 description 2
• 229920001277 pectin Polymers 0.000 description 2
• 239000001814 pectin Substances 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 206010014967 Ependymoma Diseases 0.000 description 1
• 201000004066 Ganglioglioma Diseases 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• 201000010915 Glioblastoma multiforme Diseases 0.000 description 1
• 102000008100 Human Serum Albumin Human genes 0.000 description 1
• 108091006905 Human Serum Albumin Proteins 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 201000010133 Oligodendroglioma Diseases 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 208000005017 glioblastoma Diseases 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 201000004058 mixed glioma Diseases 0.000 description 1
• 206010073131 oligoastrocytoma Diseases 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1